ArticleOncotarget2017

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial.

Jobst C von Einem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.